PINK1 deficiency impairs mitochondrial homeostasis and promotes lung fibrosis
Open accessThe DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Abstract
Although aging is a known risk factor for idiopathic pulmonary fibrosis (IPF), the pathogenic mechanisms that underlie the effects of advancing age remain largely unexplained. Some age-related neurodegenerative diseases have an etiology that is related to mitochondrial dysfunction. Here, we found that alveolar type II cells (AECIIs) in the lungs of IPF patients exhibit marked accumulation of dysmorphic and dysfunctional mitochondria. These mitochondrial abnormalities in AECIIs of IPF lungs were associated with upregulation of ER stress markers and were recapitulated in normal mice with advancing age in response to stimulation of ER stress. We found that impaired mitochondria in IPF and aging lungs were associated with low expression of PTEN-induced putative kinase 1 (PINK1). Knockdown of PINK1 expression in lung epithelial cells resulted in mitochondria depolarization and expression of profibrotic factors. Moreover, young PINK1-deficient mice developed similarly dysmorphic, dysfunctional mitochondria in the AECIIs and were vulnerable to apoptosis and development of lung fibrosis. Our data indicate that PINK1 deficiency results in swollen, dysfunctional mitochondria and defective mitophagy, and promotes fibrosis in the aging lung.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Of note, the levels of PINK1 decline with age, suggesting that a time‐dependent drop in mitophagy proficiency may contribute to the development of pulmonary fibrosis in aged individuals (Bueno et al, 2015).”
From Autophagy in major human diseases (2021) · cites this paper as Bueno et al, 2015
In the citing paper
“| Pulmonary fibrosis | Whole‐body deletion of Pink1 | Accelerated development of bleomycin‐induced lung fibrosis linked to accumulation of dysfunctional mitochondria in AEC cells | Bueno et al (2015) |”
From Autophagy in major human diseases (2021) · cites this paper as Bueno et al (2015)
In the citing paper
“Of note, the levels of PINK1 decline with age, suggesting that a time‐dependent drop in mitophagy proficiency may contribute to the development of pulmonary fibrosis in aged individuals (Bueno et al, 2015).”
From Autophagy in major human diseases (2021) · cites this paper as Bueno et al, 2015
In the citing paper
“In accordance with this notion, genetic loss of Pink1 and Prkn accelerates the development of the fibrotic phenotype in bleomycin‐treated mice, linked to alveolar epithelial cell II (AECII) loss and accrued inflammation (Bueno et al, 2015; Kobayashi et al, 2016).”
From Autophagy in major human diseases (2021) · cites this paper as Bueno et al, 2015
In the citing paper
“Pink1 deficiency leads to mitochondrial damage and hence promotes lung fibrosis (56), whereas a decreased expression of mitochondrial fission proteins Drp1 and mitochondrial fission 1 protein induces cellular senescence via a Pink1-dependent manner (57).”
From Impaired mitophagy leads to cigarette smoke stress‐induced cellular senescence: implications for chronic obstructive pulmonary disease (2015) · cites this paper as [56]
Citations
Cites
Circulating mitochondrial DAMPs cause inflammatory responses to injury
Zhang, Q., Raoof, M., Chen, Y., Sumi, Y., Sursal, T., Junger, W., Brohi, K., Itagaki, K., & Hauser, C. J. (2010) · Nature · doi:10.1038/nature08780 · Cited by 3,812 · cited 1×
“Mitochondrial materials such as mtDNA that leak from damaged mitochondria have been reported to elucidate inflammatory responses (48, 49).”
BackgroundHereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1
Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., et al. (2004) · Science · doi:10.1126/science.1096284 · Cited by 3,481
Youle, R. J., & Narendra, D. P. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3028 · Cited by 3,273
Fission and selective fusion govern mitochondrial segregation and elimination by autophagy
Twig, G., Elorza, A., Molina, A. J. A., Mohamed, H., Wikstrom, J. D., Walzer, G., Stiles, L., Haigh, S. E., Katz, S., Las, G., et al. (2008) · The EMBO Journal · doi:10.1038/sj.emboj.7601963 · Cited by 3,082
Clinical course and prediction of survival in idiopathic pulmonary fibrosis
Ley, B., Collard, H. R., & King, T. E. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201006-0894ci · Cited by 1,765 · cited 1×
“The median age of diagnosis of IPF is approximately 66 years (4, 5).”
BackgroundTelomerase Mutations in Families with Idiopathic Pulmonary Fibrosis
Armanios, M. Y., Chen, J. J.-L., Cogan, J. D., Alder, J. K., Ingersoll, R. G., Markin, C., Lawson, W. E., Xie, M., Vulto, I., Phillips, J. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066157 · Cited by 1,357 · cited 1×
“Whereas the familial disease has been related to mutations in surfactant proteins and telomerase, the cause of the majority of sporadic IPF cases and the mechanisms involved in aging-related IPF susceptibility are still unknown (6, 7).”
BackgroundIncidence and Prevalence of Idiopathic Pulmonary Fibrosis
Raghu, G., Weycker, D., Edelsberg, J., Bradford, W. Z., & Oster, G. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200602-163oc · Cited by 1,310
Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure
Oka, T., Hikoso, S., Yamaguchi, O., Taneike, M., Takeda, T., Tamai, T., Oyabu, J., Murakawa, T., Nakayama, H., Nishida, K., et al. (2012) · Nature · doi:10.1038/nature10992 · Cited by 1,201
The role of mitochondria in aging
Bratic, A., & Larsson, N.-G. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64125 · Cited by 1,087 · cited 1×
“Abnormalities in mitochondria are often observed with aging, including enlargement, loss of cristae, destruction of inner membranes, swelling, and impaired respiration (12).”
BackgroundDagda, R. K., Cherra, S. J., Kulich, S. M., Tandon, A., Park, D., & Chu, C. T. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808515200 · Cited by 954
Self-citation
Research works printed but not linked: 2
- Crapo, 1978, Lab Invest., 39, 640
- Malhotra, 2011, Cold Spring Harb Perspect Biol., 3, a004424
Cited by
Items 401–500 of 624
Xia, S., Yuan, C., Long, W. S., Wu, Z., Li, X., Wang, N., Gao, M., Li, Z., Li, P., Liu, P., et al. (2025) · Toxics · doi:10.3390/toxics13060487 · Cited by 12
Antoniou, K. M., Tsitoura, E., Vasarmidi, E., Symvoulakis, E. K., Aidinis, V., Tzilas, V., Τzouvelekis, Α., & Bouros, D. E. (2021) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2020.12.007 · Cited by 12
Idiopathic Pulmonary Fibrosis: Cell Death and Inflammation Revisited
Saux, C. J. L., & Chapman, H. A. (2018) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2018-0083ed · Cited by 12
Aging in chronic lung disease: Will anti-aging therapy be the key to the cure?
Wang, W., Zhou, K., Wang, L., Qin, Q., Liu, H., Qin, L., Yang, M., Yuan, L., & Liu, C. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176846 · Cited by 10
Wang, Y., Ma, Z., Peng, W., Yu, Q., Liang, W., Cao, L., & Wang, Z. (2025) · Scientific Reports · doi:10.1038/s41598-025-88869-6 · Cited by 11
Zhou, Y., Su, W., Xu, M.-Z., Zhang, A., Li, S., Guo, H., Gong, K., Lu, K., Yu, X., Zhu, J., et al. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.119568 · Cited by 10
Pulmonary fibrosis and exosomes: pathways to treatment
Nija, R. J., & Nithya, T. G. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10855-y · Cited by 12
“As a consequence, the canonical TGF-β/SMAD signaling pathway activated in IPF drives transcriptional expression of profibrotic genes COL1A1, COL3A1, FN1, and ACTA2 that produce α-SMA, increasing ECM stiffening and remodeling [ 14 ].”
Sandbo, N. K. (2013) · Humana Press eBooks · doi:10.1007/978-1-62703-682-5_8 · Cited by 13
Parkin, PINK1 and DJ1 as possible modulators of mTOR pathway in ganglioglioma
Drapalo, K., & Jóźwiak, J. (2017) · International Journal of Neuroscience · doi:10.1080/00207454.2017.1366906 · Cited by 11
“Disturbances at the level of PINK1 might contribute to mitochondrial dysfunction and development of IPF [35,36].”
BackgroundAllicin induced AMPK signaling attenuated Smad3 pathway mediated lung fibrosis
Nakazawa, S., Hou, J., Kato, M., Togo, S., Arai, Y., Motomura, H., Kurata, K., Sueyasu, T., Hirakawa, H., Ochi, Y., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-01314-6 · Cited by 9
ER stress induced mitochondrial dysfunction drives Treg instability in coronary artery disease
Parashar, S., Oliaeimotlagh, M., Roy, P., Lyu, Q., Bellapu, A., Fomin, M., Kumar, S., Wang, Y., McSkimming, C. C., McNamara, C. A., et al. (2025) · EMBO Molecular Medicine · doi:10.1038/s44321-025-00322-3 · Cited by 10
Kim, S., Nouws, J., Ruwisch, J., Woodard, G. A., Cooley, J. C., Khoury, J., Sun, H., Doherty, E. H., Piecychna, M., Manning, E. P., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adr2277 · Cited by 11
Aging and lung diseases: Unraveling mechanisms and therapeutic targets
Zhou, Y., Chen, G., Li, X., Li, X., Lin, Z., Liu, L., Pu, D., Chen, J., Chen, Y., Lin, Z., et al. (2025) · Chinese Medical Journal - Pulmonary and Critical Care Medicine · doi:10.1016/j.pccm.2025.11.005 · Cited by 11
Zhang, Y., Meng, Z., Wu, L., Liu, X., Guo, C., Yu, J., Ming, D., Dong, S., Cao, Y., & Jiang, X. (2023) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2023/1464853 · Cited by 9
Cloonan, S. M. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201708-1593ed · Cited by 9
“Finally the exact cellular source of mtDNA in human IPF remains to be firmly solidified—do other cells that have been documented to have abnormal mitochondria, such as the epithelial cell (1, 9, 11, 13), also release this danger signal? The authors also speculate on the downstream effects of such mtDNA release, includ…”
BackgroundAging Delays Lung Repair: Insights from Omics Analysis in Mice with Pulmonary Fibrosis
Liang, J., & Ligresti, G. (2023) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2023-0171ed · Cited by 8
“Recent reports showed that the lungs of patients with IPF share common pathogenic features with bleomycin-injured old mouse lungs, including alveolar progenitor cell failure (4), cellular senescence (5), and mitochondrial dysfunction (6, 7).”
Liang, X., Zhang, T., Cheng, X., Yuan, H., Yang, N., Yao, Y., Li, X., Zhang, F., Sun, J., Li, Z., et al. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1511682 · Cited by 9
Monteleone, G., Passantino, L., Simonetti, J., Iovene, B., Varone, F., Cameli, P., Sgalla, G., & Richeldi, L. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14145100 · Cited by 9
“These changes, through reduced expression of PTEN-induced putative kinase 1, a mitochondrial regulatory kinase protein, appear to contribute to EMT and myofibroblasts differentiation leading to fibrosis [22,23].”
Ma, M., Gao, Y., Qiu, X., Gui, X., Tian, Y., Tian, M., Albertson, T. E., Kishaba, T., Tanino, Y., Sakairi, Y., et al. (2023) · Journal of Thoracic Disease · doi:10.21037/jtd-23-815 · Cited by 9
“AEC2 cells in the lungs of IPF patients show significant malformation and dysfunctional mitochondrial accumulation (22,44,45).”
InfluentialYang, F., Ma, Z., Li, W., Kong, J., Zong, Y., Wendusu, B., Wu, Q., Li, Y., Dong, G., Zhao, X., et al. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.992331 · Cited by 10
“SCD1 concentrations are down-regulated in lung tissue from patients with IPF, and SCD1 inhibition leads to endoplasmic reticulum stress and promotes pulmonary fibrosis (34).”
BackgroundTargeting mitochondrial dysfunction: an innovative strategy for treating renal fibrosis
Wu, Y.-J., Yang, Y., Yan, Y.-L., Yang, H.-Y., & Du, J. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05297-w · Cited by 11
“Furthermore, new evidence from other organs suggests that altered mitochondrial quality control capacity in different cell types may have different or even opposite effects on tissue damage and repair [148, 149].”
PINK1 deficiency alleviates bleomycin-induced pulmonary fibrosis in mice
Gu, Y., Wu, J., Wang, T., Yu, Y.-F., Han, J., Chen, Y.-L., Hu, X., Wu, M., Hu, H., Zhang, W., et al. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.111868 · Cited by 10
Cellular plasticity and regenerative mechanisms in the lung
Zaragosi, L., Salwig, I., Wasnick, R. M., Lehmann, M., & Pardo–Saganta, A. (2026) · European Respiratory Review · doi:10.1183/16000617.0168-2025 · Cited by 8
“Concurrently, autophagic flux diminishes, AMP-activated protein kinase (AMPK) signalling wanes and mechanistic target of rapamycin complex-1 (mTORC1) becomes hyperactive, a constellation that suppresses mitophagy and promotes fibroblast proliferation [196 – 198].”
Wang, L., Wan, R., Chen, X., Guo, X., Li, Z., Zhao, W., Yan, P., & Yu, G. (2022) · Canadian Respiratory Journal · doi:10.1155/2022/9663354 · Cited by 8
“Emerging evidence suggests that mitochondrial dysfunction plays important roles in the initiation and progression of multiple aged-related lung diseases, including IPF [4].”
BackgroundJeong, J. S., Yoon, Y., Kim, W., Kim, H. J., Park, H. J., Park, K. H., Lee, K.-B., Kim, S. R., Kim, S. H., Park, Y. S., et al. (2023) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2021-0459oc · Cited by 9
Arrestin beta 1 Regulates Alveolar Progenitor Renewal and Lung Fibrosis
Huang, G., Gen, Y., Kulur, V., Liu, N., Liu, X., Taghavifar, F., Liang, J., Noble, P. W., & Jiang, D. (2024) · Journal of Respiratory Biology and Translational Medicine · doi:10.35534/jrbtm.2024.10006 · Cited by 7
PINK1/Park2-Mediated Mitophagy Relieve Non-Alcoholic Fatty Liver Disease
Hen, H., Tang, Y., Zhuang, L., Zheng, Y., & Huang, X. (2024) · Physiological Research · doi:10.33549/physiolres.934925 · Cited by 19
Aging-Associated Metabolite Methylmalonic Acid Increases Susceptibility to Pulmonary Fibrosis
Xu, K., Ding, L., Li, W., Wang, Y., Ma, S., Lian, H., Pan, X., Wan, R., Zhao, W., Yang, J., et al. (2024) · American Journal Of Pathology · doi:10.1016/j.ajpath.2024.04.011 · Cited by 9
Wang, Y., Chen, S., Chen, S., & Jiang, J. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.18414 · Cited by 7
Targeting ATAD3A Phosphorylation Mediated by TBK1 Ameliorates Senescence‐Associated Pathologies
He, Y., Liu, Y., Zheng, M., Zou, Y., Huang, M., Wang, L., Gao, G., Zhou, Z., & Jin, G. (2024) · Advanced Science · doi:10.1002/advs.202404109 · Cited by 8
Yousef, A., Fang, L., Heidari, M., Kranrod, J. W., & Seubert, J. M. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1486717 · Cited by 10
Genomic Fingerprint Associated with Familial Idiopathic Pulmonary Fibrosis: A Review
Ding, D., Gao, R., Xue, Q., Luan, R., & Yang, J. (2023) · International Journal of Medical Sciences · doi:10.7150/ijms.80358 · Cited by 8
“In humans, they occur in lung and AT2 epithelial cells of patients with f-IPF and s-IPF alike (173).”
BackgroundLiang, Y., Fan, S., Jiang, Y., Ji, T., Chen, R., Xu, Q., Liu, Y., Xiao, Y., Cai, H., & Dai, J. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110754 · Cited by 7
Thyroid hormone: a resurgent treatment for an emergent concern
Breitzig, M., Alleyn, M. D., Lockey, R. F., & Kolliputi, N. (2018) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00336.2018 · Cited by 12
“It is believed that PTEN-induced putative kinase 1 (PINK1) is one of the critical determinants in the preservation of mitochondria, a protein also shown to have decreased expression in the lung tissues of IPF patients (3, 12, 67).”
BackgroundZhao, Y., Hou, W., Yang, L., Chen, K., Lang, Q., Sun, W., & Gao, L. (2025) · Journal of Proteomics · doi:10.1016/j.jprot.2025.105400 · Cited by 9
Fueling the fire: metabolic dysfunction and senescence as drivers of lung aging and disease
Kliment, C. R., Gurkar, A. U., Cárdenes, N., Ramonell, R. P., Finkel, T., & Königshoff, M. (2026) · Physiological Reviews · doi:10.1152/physrev.00024.2025 · Cited by 7
Epithelial stem cells at the intersection of tissue regeneration and pulmonary fibrosis
Platé, M., Kobayashi, Y., Chambers, R. C., & Tata, P. R. (2021) · European Respiratory Society eBooks · doi:10.1183/2312508x.10010420 · Cited by 6
Huang, F., Ding, G., Yuan, Y., Lijun, Z., Ding, W., & Wu, S. (2023) · Toxics · doi:10.3390/toxics11070578 · Cited by 6
“[34] also found that after knocking out the PTEN gene in alveolar epithelial cells, the degree of pulmonary fibrosis was aggravated.”
Mechanisms of Fibroblast Activation during Fibrotic Tissue Remodeling
Rigau, A. R., & Dees, C. (2024) · Fibrosis · doi:10.35534/fibrosis.2024.10002 · Cited by 7
The multifaceted role of macrophage mitophagy in SiO2‐induced pulmonary fibrosis: A brief review
Zhou, Y., Li, S., Du, S., Zhao, J., Cai, Y., & Zhang, Z. (2024) · Journal of Applied Toxicology · doi:10.1002/jat.4612 · Cited by 8
“…found that downregulation of mitophagy leads to accumulation of dysfunctional mitochondria (D. Narendra, Tanaka, Suen, & Youle, 2008), significant changes in mitochondrial homeostasis, and mitochondrial damage ( ´ Alvarez et al., 2017; Bueno et al., 2015) during the formation of pulmonary fibrosis.”
The Role of Epithelial Cell Quality Control in Health and Disease of the Distal Lung
Beers, M. F., Nureki, S., & Mulugeta, S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803809-3.00008-7 · Cited by 7
Extracellular Vesicles: Bidirectional Accelerators of Cellular Senescence in Fibrosis?
Goliwas, K. F., & Deshane, J. S. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2020-0313ed · Cited by 6
“AT2 cell senescence has been linked to mitochondrial dysfunction (6).”
BackgroundMitochondrion in Pulmonary Disease: Small Organelle but Big Function
Wang, J., Wu, H., Gao, J., & Zhang, T. (2025) · Small Methods · doi:10.1002/smtd.202500674 · Cited by 7
From Fibrosis to Malignancy: Mechanistic Intersections Driving Lung Cancer Progression
Chen, B., Hamdy, H., Zhang, X., Cao, P., Fu, Y., & Shen, J. (2025) · Cancers · doi:10.3390/cancers17233861 · Cited by 6
“Excessive mitophagy may deplete functional mitochondria and impair energy metabolism, while insufficient mitophagy promotes oxidative damage [111].”
Liu, B., Han, Y., Jin, Y., Ye, M., Yang, Z., Yang, J. H., Zhu, M., Zhao, X., Jin, Y., & Yin, Y. (2025) · Nature Communications · doi:10.1038/s41467-025-66901-7 · Cited by 5
SAT0051 BARICITINIB IMPROVES JOINT MOBILITY AFTER INJURY IN A RODENT FORCED-AMBULATION MODEL
Knopp, K. L., Kato, A., Wall, T. M., McDermott, J. S., Nisenbaum, E. S., Adams, B., & Johnson, M. P. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-eular.1751 · Cited by 5
BAG3: An enticing therapeutic target for idiopathic pulmonary fibrosis
Chillappagari, S., Günther, A., & Mahavadi, P. (2023) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30446 · Cited by 5
“6,7 Poly-ubiquitinated proteins, enhanced sequestosome1 (SQSTM1/p62) with insufficient autophagy and mito-phagy are reported in fibroblasts as well as AT2 of IPF lungs, in both spontaneous 3,4 and familial forms and in animal models of lung fibrosis 8 – 11 (Figure 1).”
Pathogenesis and Therapy of Hermansky–Pudlak Syndrome (HPS)-Associated Pulmonary Fibrosis
Hu, X. M., Wei, Z., Wu, Y., Zhao, M., Zhou, L., & Lin, Q. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252011270 · Cited by 8
“…activators Yes-associated protein (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ) in the Hippo signaling pathway have been identified as a key regulator in the regeneration and repair of alveolar epithelial cells, as well as in preventing remodeling in fibrosis [101].”
BackgroundAberrant Expression of ACO1 in Vasculatures Parallels Progression of Idiopathic Pulmonary Fibrosis
Fukumoto, J., Lin, M., Banday, M. M., Patil, S. S., Krishnamurthy, S., Breitzig, M., Soundararajan, R., Galam, L., Narala, V. R., Johns, C., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.890380 · Cited by 7
“It is hypothesized that the accumulation of cis-aconitate in IPF is mediated by a representative non-mitochondrial aconitase isoform, ACO1 (cytoplasm-localized aconitase isoform), since mitochondrial functions are impaired in IPF (Bueno et al., 2015; Rangarajan et al., 2017; Schuliga et al., 2018; Caporarello et al.,…”
BackgroundKarampitsakos, Τ., Galaris, A., Barbayianni, I., DeIuliis, G., Ahangari, F., Sampsonas, F., Sotiropoulou, V., Aidinis, V., Bennett, A. M., Herazo‐Maya, J. D., et al. (2023) · Diagnostics · doi:10.3390/diagnostics13061166 · Cited by 6
“PINK1 deficiencyinduced mitochondrial function derangements have been associated with enhanced AECIIs apoptosis [14] and reduced fibroblasts-to-myofibroblasts differentiation [32].”
BackgroundSelf-citationEvolutionary genetics of pulmonary anatomical adaptations in deep-diving cetaceans
Guo, B., Sun, Y., Wang, Y., Zhang, Y. P., Yu, Z., Xu, S., Yang, G., & Ren, W. (2024) · BMC Genomics · doi:10.1186/s12864-024-10263-9 · Cited by 11
“In mice, the reduction of PINK1 expression in lung epithelial cells resulted in mitochondrial depolarization and the expression of profibrotic factors [98].”
BackgroundCigarette and e-cigarette reversely regulated autophagy via distinct level of ROS in vitro
Wang, Y., Zhong, J., Jin, Z., Luo, A., Wu, Z., Jiang, X., Chen, J., Liu, P., & Li, M. (2024) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2024.117448 · Cited by 5
Lian, H., Xu, K., Chang, A., Wang, Y., Ma, S., Cheng, L. C., Zhao, W., Xia, C., Wang, L., & Yu, G. (2024) · Respiratory Research · doi:10.1186/s12931-024-03041-4 · Cited by 6
“Abundant mitochondrial abnormalities have been observed in AEC2 derived from patients with IPF and in mice treated with bleomycin (BLM) [14, 15].”
Mechanisms and markers of lung ageing in health and disease
Miller, Z., Twardowski, L.-M., Reader, B. F., Rojas, M. M., Lehmann, M., & Mora, A. L. (2025) · European Respiratory Review · doi:10.1183/16000617.0233-2024 · Cited by 14
“Lung: ↑ mitochondrial stress/damage [16, 247, 248], ↓ ANT1 [37] Blood: ↑ mtDNA [32, 179], ↑ mtDNA/nDNA [249], ↑ oxidative stress [147] BALF: ↑ mtDNA [32, 108, 179], ↓ mitochondrial quality control [181], ↑ ROS [181] Lung: ↑ mitochondrial stress/damage [44, 250], ↓ / ↑ mitochondrial function [16,…”
Self-citationOgasawara, M., Otani, M., Takano, M., Shudou, M., Inaba, Y., Nirasawa, S., Takahashi, S., Kiyoi, T., Tanaka, Y., Kameda, K., et al. (2016) · Experimental Lung Research · doi:10.1080/01902148.2016.1197984 · Cited by 6
“IPF patients has shown that expression of Pink1 involved in mitochondrial quality control was significantly decreased and that mitochondrial ultrastructure and function was impaired.[41] This study indicated that homeostasis of mitochondrial dynamics is crucial and impairments of mitochondrial homeostasis are strongly…”
BackgroundLost in Translation: Endoplasmic Reticulum–Mitochondria Crosstalk in Idiopathic Pulmonary Fibrosis
Bueno, M., & Rojas, M. M. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2020-0273ed · Cited by 7
“resolve ER stress because of an impairment in autophagy (6).”
BackgroundSelf-citationRai, P., & Fessler, M. B. (2021) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2021-0055ed · Cited by 5
Farkas, L., Horowitz, J. C., & Mora, A. L. (2022) · European Respiratory Journal · doi:10.1183/13993003.01702-2022 · Cited by 5
Self-citationZhou, Y., Wang, Z., Zhao, H., Liu, Y., Lin, Y., Zhang, J., Li, X., Zhang, B., Xie, J., An, X., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07025-w · Cited by 5
“…then the binding of Ub to microtubule-associated protein 1 light chain 3 (LC3) and sequestosome 1 (SQSTM1/p62) serves as a signal for initiating the autophagic machinery, leading to the fusion of ubiquitinated mitochondria with lysosomes in cells, thereby eliminating damaged mitochondria [32–35].”
Han, L., Wang, C., Guo, X., Luo, Y., Zhang, J., He, F., Zeng, Z., Jiang, L., Ouyang, W., Gong, Y. Q., et al. (2025) · Advanced Science · doi:10.1002/advs.202509973 · Cited by 9
Tang, X., Wei, W., Sun, Y., Weaver, T. E., Nakayasu, E. S., Clair, G., Snowball, J. M., Na, C.-L., Apsley, K. S., Martin, E. P., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci173861 · Cited by 6
Ban, J., Zhang, Q., Chang, S., Qu, H., & Liu, F. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110508 · Cited by 4
Mutairy, E. A., Qattan, S. M. A., Khalid, M., Al-Enazi, A. A., Al‐Saif, M., Imtiaz, F., Ramzan, K., Raveendran, V. V., Alaiya, A. A., Meyer, B. F., et al. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1282868 · Cited by 5
Tao, H., Lv, Q., Zhang, J., Chen, L., Yang, Y., & Sun, W. (2024) · Stem Cells International · doi:10.1155/2024/3429565 · Cited by 5
Dong, Z., Wang, X., Wang, P., Bai, M., Wang, T., Chu, Y., & Qin, Y. (2024) · Advanced Biology · doi:10.1002/adbi.202400297 · Cited by 6
Hofstadter, W. A., Park, J. W., Lum, K. K., Chen, S., & Cristea, I. M. (2024) · Journal of Virology · doi:10.1128/jvi.01099-24 · Cited by 5
Organellar quality control crosstalk in aging‐related disease: Innovation to pave the way
Li, Y., Qi, J., Guo, L., Jiang, X. L., & He, G. (2024) · Aging Cell · doi:10.1111/acel.14447 · Cited by 5
SIRT3/6/7: promising therapeutic targets for pulmonary fibrosis
Huang, P., Du, Q., Qin, Y., Tao, S., & Liu, G. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1557384 · Cited by 9
Elajaili, H. B., Hernandez‐Lagunas, L., Harris, P. S., Sparagna, G. C., Jonscher, R. L., Ohlstrom, D. J., Sucharov, C. C., Bowler, R. P., Suliman, H. B., Fritz, K. S., et al. (2022) · Advances in Redox Research · doi:10.1016/j.arres.2022.100035 · Cited by 4
Zhang, Y., Zhang, W., Shi, J., Yu, T., Yu, J., Du, S., He, S., & Song, K. (2019) · Journal of King Saud University - Science · doi:10.1016/j.jksus.2019.11.029 · Cited by 4
Retrograde mitochondrial signaling governs the identity and maturity of metabolic tissuesPreprint
Pearson, G. L., Walker, E. M., Lawlor, N. T., Lietzke, A. C., Sidarala, V., Zhu, J., Stromer, T., Reck, E. C., Stendahl, A. M., Li, J., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.08.02.502357 · Cited by 4
Matsuda, E., Hasebe, S., Matsuzaka, T., Hayashi, A., Ohno, H., Motomura, K., Sakka, S., Kohno, S., Muranaka, H., Yamamura, M., et al. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.168023 · Cited by 5
Wang, J. Y., & Young, L. R. (2025) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2025.07.009 · Cited by 3
Chang, M., Zhou, Q., Guan, Y., Zhao, Y., Guo, S., Qu, Q., Liu, L., Li, Z., Zhao, X., Cao, H., et al. (2026) · Antioxidants and Redox Signaling · doi:10.1177/15230864251411565 · Cited by 3
Lin, Y., Lei, T., Jia, Y., Yao, M., Wang, X., Huang, S., Wang, Z., & Lai, X. (2026) · Autophagy · doi:10.1080/15548627.2026.2642341 · Cited by 4
“Accumulating evidence indicated that impaired mitophagy drives myofibroblast activation and pulmonary fibrosis progression [1,13,14].”
InfluentialALKBH3 m1A Demethylase Deficiency Reduces Alzheimer's Amyloid‐β Pathology
Li, Y., Yu, S. M., Lu, K., Zhang, Y., Dong, M., Peng, Y., Xue, L., Alam, W., Shui, Y., Zhou, Y., et al. (2026) · Advanced Science · doi:10.1002/advs.202522572 · Cited by 5
“Supporting this connection, PINK1 expression is reduced in AD patient samples (Figure 3d ), and we identified it as a direct m1A target of ALKBH3 (Figure 3e, Table S1 ) [ 55, 60 ].”
The metabolic code of pulmonary disease: from mechanisms to therapeutic opportunities
Kearney, E., Tan, S.-Y., Wang, Z., & Dowling, C. M. (2026) · Breathe · doi:10.1183/20734735.0260-2025 · Cited by 3
“Fibrotic lungs exhibit significant mitochondrial dysfunction, which complements the shift towards glycolysis [81].”
InfluentialDeletion of Miro1 in airway club cells potentiates allergic asthma phenotypes
Bruno, S. R., Lamberty, A., McCoy, M., Mark, Z. F., Daphtary, N., Aliyeva, M., Butnor, K. J., Poynter, M. E., Anathy, V., & Cunniff, B. (2023) · Frontiers in Allergy · doi:10.3389/falgy.2023.1187945 · Cited by 3
“Moreover, Miro1 plays a critical role in signaling for mitophagy and interacting with the Pink1/Parkin mitochondrial quality control system (61, 62), and compromised degradation of Parkin has been shown to promote inflammation and the release of mtDNA (63).”
BackgroundLi, X., Lin, Q., Guan, B., Yang, M., Huang, X., Li, L., Chen, C., Hong, J., & Zhang, M. (2025) · Translational research · doi:10.1016/j.trsl.2025.02.002 · Cited by 4
Pathophysiology of small airways in idiopathic pulmonary fibrosis (IPF): the silent zone
Lu, W., Shahzad, A. M., Simon, A. A., Haug, G., Waters, M., & Sohal, S. S. (2025) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2025.2467341 · Cited by 4
“In IPF, alveolar type-2 epithelial cells have a reduced ability to regenerate and mitochondrial dysfunction impairs autophagy [63].”
Modeling the impact of low-dose particulate matter on lung health
Schuliga, M. J., & Bartlett, N. W. (2019) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00343.2019 · Cited by 3
Epithelial Ablation of Miro1/Rhot1 GTPase Augments Lung Inflammation by Cigarette Smoke
Sharma, S., Wang, Q., Muthumalage, T., & Rahman, I. (2021) · Pathophysiology · doi:10.3390/pathophysiology28040033 · Cited by 3
“Miro1 also serves a vital role in mitochondrial dynamics by its interaction with Pink1 (PTEN-induced putative kinase 1)/Parkin mitochondrial quality control system by serving as a signal for mitophagy (Bueno et al., 2015; Safiulina et al., 2019).”
BackgroundKandasamy, J., Li, R., Vamesu, B. M., Olave, N. C., Halloran, B., Jilling, T., Ballinger, S. W., & Ambalavanan, N. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.17.541177 · Cited by 4
“Impaired PINK1/Parkin-mediated mitophagy contributes to the accumulation of damaged mitochondria and has been implicated in disorders such as COPD and IPF [57,58].”
BackgroundInfluentialPolverino, F., & Mora, A. L. (2024) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2023-0432ed · Cited by 3
“Thestudy from Hayek and colleagues highlights that AT2 cells from IPF lungs have robust defects in mitochondrial homeostasis (20) and metabolic components characterized by lipid or fatty acid dysmetabolism.”
BackgroundSelf-citationSchumann, A., Martínez‐Pizarro, A., Richard, E., Schell, C., Koessinger, A. L., Zeyer, K. A., Tholen, S., Schilling, O., Barry, M. A., Neubauer, B., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-79572-z · Cited by 3
“Investigation of distinct disease entities like lung fibrosis 39 and neurodegenerative disorders 40,41 revealed a similar pattern.”
Zifa, E., Sinis, S. I., Psarra, A. G., Mouikis, A., Pozantzi, A., Rossi, K., Malli, F., Dimeas, I. E., Kirgou, P., Gourgoulianis, K. I., et al. (2025) · Biochemical Genetics · doi:10.1007/s10528-025-11071-w · Cited by 2
“The average Complex I activity was 57.2 ± 4.8 nmol/mg protein/min, with an interassay variation of 43.44%, consistent with previously published data on human lymphocytes (Bueno et al. 2015 Feb).”
InfluentialWang, J., Yu, H., Lei, S.-Y., Ruan, H., Guo, X., & Li, J. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01821-6 · Cited by 4
“Aging is a risk factor for many chronic diseases and promotes lung function decline and susceptibility to chronic lung diseases [63, 64].”
Du, D., Yang, T., Wan, H., & Luo, F. (2025) · Therapeutic Advances in Respiratory Disease · doi:10.1177/17534666251374241 · Cited by 3
“15,16 As the association between mitochondrial dysfunction and PF has been widely reported, 17,18 mitochondrial dysfunction may serve as another essential driver of HPS-related PF. Excessive reactive oxygen species caused by mitochondrial dysfunction may also promote PF via fibroblast activation…”
Song, T., Bu, M., Song, Q., Zhan, B., Liu, W., Hu, M., Xu, G., Yang, Z., Zhao, K., Bai, Y., et al. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.168100 · Cited by 4
Shionone ameliorates pulmonary fibrosis by activating mitophagy via PINK1-Parkin pathway
Su, Y., Fu, Q., Wu, X., Che, X., Jiang, Z., & Li, X. (2025) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2025.117693 · Cited by 2
Mitochondrial Dysfunction in Renal Aging: A Vicious Cycle Driving Kidney Disease Progression
Yu, W., Ouyang, Q., Liu, W., Jia, L., & Wang, B. (2026) · Antioxidants and Redox Signaling · doi:10.1177/15230864251410936 · Cited by 4
Chitale, A., Verma, S., & Mugale, M. N. (2026) · Cell Biochemistry and Function · doi:10.1002/cbf.70203 · Cited by 3
“In asthma and COPD, ER‐UPR activation and mitochondrial dysfunction contribute to autophagy by activating the ERN1/XBP1 pathway and apoptosis through activation of JNK/p38 MAPK and EIF2AK3‐ ATF4‐DDIT3 pathways [86–88].”
Mitophagy promotes lung repair and regeneration by restoring epithelial metabolic fitness
Wu, P., Chen, J., Liu, L., Wang, P., Lu, T., Shen, S., Cao, Y., Sui, Y., Liu, R., Huan, X., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-71728-x · Cited by 2
Naikawadi, R. P., & Wolters, P. J. (2021) · European Respiratory Journal · doi:10.1183/13993003.04500-2020 · Cited by 2
Amin, R., Pandey, R., Vaishali, K., Acharya, V. K., Sinha, M. K., & Kumar, N. (2023) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557523666230816090112 · Cited by 4
Role of Immune Cells in Mediating the Effect of Hypothyroidism on Idiopathic Pulmonary Fibrosis
Liu, Z., Kou, C., Chen, X., Yang, J., Zhu, H., Jiao, Y., Zhang, D., Zhang, W., & Li, L. (2025) · The Clinical Respiratory Journal · doi:10.1111/crj.70111 · Cited by 2
“Previous studies have demonstrated that mitochondrial dysfunction is a key feature of IPF [26], while evidence from animal studies has indicated that thyroid hormones may suppress pulmonary fibrosis by enhancing mitochondrial activity in lung epithelial cells [27].”
Targeting E3 ubiquitin ligases: a new frontier in idiopathic pulmonary fibrosis treatment
Zhang, K., Yuan, H., & Shi, L. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1618424 · Cited by 6
Zhou, S., Dong, Y.-X., Tian, J., Che, G., & Lai, Y. (2025) · Regenerative Therapy · doi:10.1016/j.reth.2025.09.005 · Cited by 3
Self-citationSaha, S., Majumdar, S., & Bhattacharyya, P. (2023) · Springer eBooks · doi:10.1007/978-981-99-3505-5_7 · Cited by 2
Aging in COPD and Idiopathic Pulmonary Fibrosis
Sánchez, C. G. (2015) · Springer eBooks · doi:10.1007/978-3-319-23246-1_15 · Cited by 2
Metadata
- Authors
- Bueno, M., Lai, Y.-C., Romero, Y., Brands, J., St. Croix, C. M., Kamga, C., Corey, C., Herazo-Maya, J. D., Sembrat, J., Lee, J. S., Duncan, S. R., Rojas, M., Shiva, S., Chu, C. T., & Mora, A. L.
- Affiliations
- University of Pittsburgh (US)
- Universidad Nacional Autónoma de México (MX)
- Corresponding author
- Mora, Ana L.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2014-12-22
- Volume
- 125
- Issue
- 2
- Pages
- 521-538
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC4319413
- OpenAlex
- W2054760729
- Cited by
- 627
- References
- 65
- Citations by year
- 2026: 50 · 2025: 63 · 2024: 74 · 2023: 63 · 2022: 49 · 2021: 68 · 2020: 59 · 2019: 57 · 2018: 49 · 2017: 42 · 2016: 33 · 2015: 18
- FWCI
- 24.88
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Pittsburgh
- Hemophilia Center of Western Pennsylvania
- National Institutes of Health (DK072506, NS065789)
- National Institute on Aging (AG026389, R01AG026389)
- National Heart, Lung, and Blood Institute (R01HL086884, R01HL123766)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK072506)
- National Institute of Neurological Disorders and Stroke (NS065789, R01NS065789, R56NS065789)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- PINK1, idiopathic pulmonary fibrosis, lung aging, mitochondrial dysfunction, alveolar type II cells, endoplasmic reticulum stress, mitophagy, mitochondrial depolarization, apoptosis, mitochondrial homeostasis
- MeSH terms
- PTEN-Induced Putative Kinase, Aging, Animals, Humans, Mice, Inbred BALB C, Mitochondria, Protein Kinases, Pulmonary Alveoli, Up-Regulation, Apoptosis, Mice, Knockout, Cell Line, Tumor, Mice, Idiopathic Pulmonary Fibrosis, Endoplasmic Reticulum Stress, Mitophagy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.